MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Dopamine Agonists and Postural Disorders in Parkinson’s disease

    L. Ameghino, V. Bruno, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the relationship between treatment with DA and the development of postural disorders (CC, PS and AC) in patients with PD.  Background: Stood…
  • 2017 International Congress

    Imbalance between dopaminergic and cholinergic neurotransmission following rotenone administration suggestive of Parkinson’s-like symptoms in male rats

    S. Madiha, S. Haider (Karachi, Pakistan)

    Objective: In the present study we analyzed rotenone-induced gait abnormalities, muscular weakness and locomotor deficits in rats. The study also evaluated the effects of rotenone…
  • 2017 International Congress

    Substantia nigra hyperechogenicity in male methamphetamine users

    G. Todd, V. Pearson-Dennett, B. Collie, J. White (Adelaide, Australia)

    Objective: To investigate the effect of sex on substantia nigra (SN) echogenicity in young-to-middle aged adults with a history of methamphetamine use. Background: The sonographic…
  • 2017 International Congress

    Motor dysfunctions in rats following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin

    R. Shukla, R. Gupta, A. Pant, V. Khanna (Lucknow, India)

    Objective: To investigate the targets associated in regulating motor functions following subsequent exposure to stress on the neurotoxicity of lambda-cyhalothrin in rats. Background: Stress that…
  • 2017 International Congress

    D2 receptor mediated DARPP32/PP1α signaling is responsible for cadmium induced Parkinson’s like behavioral alterations in rats

    R. Gupta, R. Shukla, V. Khanna (Luckno, India)

    Objective: To identify the specificity of dopamine D2 receptor mediated signaling in cadmium mediated motor alterations Background: Cadmium, a heavy metal, is to known to…
  • 2017 International Congress

    Risk of Parkinson’s disease in zolpidem user: A systematic review and meta-analysis

    S. Hussain, A.K. Najmi, D. Anil (New Delhi, India)

    Objective: To explore the association between zolpidem use and risk of Parkinson's disorder. Background: Zolpidem is commonly prescribed for the treatment of sleep disorder. Epidemiological…
  • 2017 International Congress

    An Unusual Cause of Rhabdomyolysis in Parkinson’s disease

    Y. Pitakpatapee, C. Satukijchai, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To describe an unusual cause of rhabdomyolysis in patient with advanced Parkinson’s disease (PD) treated with levodopa. Background: Rhabdomyolysis is a serious and life-threatening…
  • 2017 International Congress

    Reversible progressive supranuclear palsy-mimic induced by risperidone

    H.J. Kim, J.H. Lee (Seoul, Republic of Korea)

    Objective: To report a patient who presented with a progressive supranuclear palsy (PSP)-like syndrome while receiving risperidone that disappeared after drug withdrawal. Background: Drugs that…
  • 2017 International Congress

    Tardive syndromes induced by coadministration of tramadol and sertralin

    H. Sarac, N. Bozina, N. Henigsberg, L. Bagaric-Krakan (Zagreb, Croatia)

    Objective: To illustrate the possible association of tardive syndromes (TS) and coadministration of tramadol and sertraline in three patients. Background: TS is delayed onset of…
  • 2017 International Congress

    Tacrolimus induced parkinsonism presenting as freezing of gait and speech

    V. Paramanandam, H. DS, P.C. N (Chennai, India)

    Objective: Tacrolimus a calcineurin inhibitor is the most widely used immunosuppressant in post transplant patients. Mild adverse effects like tremors and parasthesia and occasionally major…
  • « Previous Page
  • 1
  • …
  • 1414
  • 1415
  • 1416
  • 1417
  • 1418
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley